Abstract:To evaluate the long term effect of 582 nasopharyngeal carcinoma (NPC) patients treated with intensity modulated radiotherapy (IMRT) and to analyze the prognostic factors. Five hundred eighty-two NPC patients treated with IMRT in Si Chuan Cancer Hospital from Jan.2001 to Dec.2004 were reviewed retrospectively. According to 2002 UICC staging system, 36 patients had Stage I, 144 Stage II, 224 Stage III, and 178 Stage IV lesions. One hundred ninety-eight patients only received radical IMRT, while 384 patients received IMRT combined with chemotherapy. The prescription dose was delivered as follows: gross target volume (GTVnx) received 68 – 76 Gy in 30 – 33 fractions, positive neck lymph nodes (GTVln-R/L) received 60 – 70 Gy in 30 – 33 fractions, high-risk clinical target volume (CTV1) received 60 – 66 Gy, low-risk clinical target volume (CTV2) received 54 – 60 Gy, clinical target volume of cervical lymph node regions (CTVln) received 50 – 55 Gy. The Kaplan-Meier method was used to calculate the local-regional control rate (LC), regional control rate (RC), distant metastasis-free survival rate (DMSF), disease-free survival rate (DFS), disease-specific survival rate (DSS) and overall survival rate (OS). Log-rank test was used for the univariate analysis, and Cox proportional hazard model for the multivariate analysis. Acute and late toxicities were graded according to the RTOG radiation morbidity scoring criteria. The median follow-up interval was 66.4 months. There were 29, 13 and 117 patients who had developed local, regional and distant recurrence respectively. The 133 patients died. The 5-year LC, RC, DMFS, DFS, DSS and OS was 89.8%, 95.2%, 74.1%, 69.6%, 83.2% and 77.1%. The incidence of Grade 3 acute and late toxicity was 38.3% and 4.24%. Xerostomia was the most common late toxicity. No patient had occurred Grade 4 toxicities. The 5-year DMFS of IMRT and IMRT combined with chemotherapy was 73.2% and 78.0%, the OS of them was 75.8% and 79.2%. The 5-year LC of GTVnx 30 cm3 (93.6% vs. 80.4%, p < 0.05). The 5-year RC of GTVln 10 cm3 (96.3 vs. 85.0%, p < 0.05). Univariate analysis revealed that gender, T/N-Stage, clinical stage, radiotherapy interruption, HGB, biological dose of GTVnx, lose weight and chemotherapy was the significant prognostic factor for the OS. Meanwhile, multivariate analysis showed that clinical stage, N-Stage, chemotherapy, radiotherapy interruption, the volume of GTVnx, age, HGB, gender, and loss weight was the independent prognostic factors for the OS in order. IMRT technique has dramatically improved the clinical effect of nasopharyngeal carcinoma, especially for the LC and RC. The late toxicities were acceptable. Distant metastasis was the main cause of failure.

Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-up

Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era.

Long-term Outcomes of Nasopharyngeal Carcinoma Patients with T1-2 Stage in Intensity-Modulated Radiotherapy Era.

Long-term Efficacy and Adverse Effects of Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma

Ten-Year Results of Intensity-Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma: New Insight into the Value of Concurrent Chemotherapy

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial

Preliminary Results of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy: a Retrospective Study of 364 Patients

Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost

Clinical Outcomes and Prognostic Factors of 582 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy.

Long-term Results and Prognostic Factors in 582 Nasopharyngeal Carcinoma Treated by Intensitymodulated Radiotherapy

Reducing Target Volumes of Intensity-Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial

Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non‐metastatic stage T4 nasopharyngeal carcinoma in IMRT era

Long-term Outcomes of Induction Chemotherapy Followed by Intensity-Modulated Radiotherapy and Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients with N3 Disease

Long-term Effect and Prognostic Factors of 582 Nasopharyngeal Carcinoma Patients Treated with Intensity Modulated Radiotherapy

Sequential Chemotherapy and Intensity-Modulated Radiation Therapy in the Management of Locoregionally Advanced Nasopharyngeal Carcinoma: Experience of 370 Consecutive Cases

Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy.

Long-term survival, toxicities, and the role of chrono-chemotherapy with different infusion rates in locally advanced nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy: a retrospective study with a 5-year follow-up

Analysis of long-term survival outcomes and late radiation toxicity of 132 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy

Long-term outcomes of nasopharyngeal carcinoma treated with helical tomotherapy using simultaneous integrated boost technique: A 10-year result

Clinical outcomes for early-stage nasopharyngeal carcinoma with predominantly WHO II histology treated by intensity-modulated radiation therapy with or without chemotherapy in nonendemic region of China